CompletedPhase 4NCT01129284
Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)
Studying Idiopathic steroid-resistant nephrotic syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Columbia University
- Principal Investigator
- Gerald B Appel, MDColumbia University
- Intervention
- ACTHAR gel(drug)
- Enrollment
- 15 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2009 – 2011
Study locations (1)
- Columbia University Medical Center, New York, New York, United States
Collaborators
Mallinckrodt
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01129284 on ClinicalTrials.gov